Table 3.
Comparison of patient’s characteristics with published case series
| author | year | cases | Age(yrs) | Size(cms) | ca-125 (U/ml) |
mitotic rate (per HPF) |
residual disease |
adjuvant therapy |
follow up(mon) |
outcome |
|---|---|---|---|---|---|---|---|---|---|---|
| Munoz | 2010 | 6 | 42 50 79 54 46 65 |
6 × 6 × 4 6 × 4.5 × 3.5 27 × 34 12 × 10 × 7 33 × 32 10 |
23.6 15 1.62 16.5 34.4 156 |
<5/50 3/50 28/50 none none >12/50 |
no no no no yes no |
no no imatinib no imatinib no |
40 36 34 30 18 died |
disease free disease free disease free disease free disease control died |
| Present study | 2015 | 10 | 60 55 50 45 41 39 41 55 63 70 |
24 × 12.9 × 21.5 16x14x9.5 3.9 × 3 19x24x15 8x6x10 7x12x10 20x20x18 13x13x14 10x8x8 18x11x20 |
10.9 161 6.5 59.8 32.2 27.4 6.8 16.4 25 8.5 |
>5/50 >5/50 >5/50 >5/50 >5/50 >5/50 >5/50 <5/50 >5/50 <5/50 |
no no no no no no no no no no |
- imatinib imatinib imatinib imatinib imatinib/ sunitinib imatinib imatinib imatinib imatinib |
Lost Lost 47 40 36 Died 14 13 7 2 |
- - Disease free Disease free Disease free Died Disease free Disease free Disease free Disease free |